TrialClinical and translational medicine2026

Circulating tumour DNA to guide rechallenge with cetuximab plus irinotecan in RAS/BRAF wild-type metastatic colorectal cancer: A nonrandomised clinical trial.

De-Shen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.